Aadi Bioscience, Inc. (NASDAQ:AADI) Q2 2023 Earnings Call Transcript

Page 4 of 4

Roger Song: Excellent. Thank you. Maybe just last one. For the ECC and the NETs study, would you be able to guide a little bit about the initial data we can start to see? Thank you.

Loretta Itri: Well, the first patient is in. Both studies are anticipated to begin enrolling in this calendar year. So I would anticipate, since they are two-stage studies that we should have something to report out, even early data, probably some time next year.

Roger Song: Great. Thank you, Loretta. Thanks for taking the question. That’s it from me. Thank you.

Loretta Itri: Thank you.

Operator: I would now like to turn the conference back to Scott Giacobello for closing remarks.

Scott Giacobello: Great. Thanks, everyone, for taking the time to join our call today. As you can see, we’ve got a lot going on, and we’re looking forward to updating you as year progresses.

Operator: This concludes today’s conference call. Thank you for participating. You may now disconnect.

Follow Aadi Bioscience Inc. (NASDAQ:AADI)

Page 4 of 4